The Scale of the Challenge: Overview and Case Studies
Welcoming Remarks: Richard N. Haass, President, Council on Foreign Relations
Opening Remarks: Margaret Hamburg, Commissioner, U.S. Food and Drug Administration
David Heymann, Head and Senior Fellow, Centre on Global Health Security, Chatham House, United Kingdom
Gary Jay Kushner, Partner and Leader, Food and Agriculture Practice Area, Hogan Lovells US, LLP
Paul B. Orhii, Director General, National Agency for Food and Drug Administration and Control, Nigeria
Presider: Richard E. Besser, Chief Health and Medical Editor, ABC News
8:15 to 9:00 AM Breakfast Reception
9:00 to 10:30 AM Meeting
Policy Challenges in a Globalized Era
Dirceu Barbano, Director-President, National Agency of Sanitary Surveillance, Brazil
Margaret Hamburg, Commissioner, U.S. Food and Drug Administration
Howard Zucker, Senior Adviser, Division of Global Health and Human Rights, Massachusetts General Hospital; Former Assistant Director-General, World Health Organization
Presider: Susan Dentzer, Editor-in-Chief, Health Affairs
10:45 AM to 12:00 PM Meeting
Caroline Smith DeWaal, Food Safety Director, Center for Science in the Public Interest
Aline Plançon, Head of INTERPOL-IMPACT Project and Head of Medical Products Counterfeiting, and Pharmaceutical Crime Unit (MPCPC), INTERPOL, France
Michael Robach, Vice President, Corporate Food Safety and Regulatory Affairs, Cargill, Inc.
Greg Simon, Senior Vice President, Worldwide Policy, Pfizer, Inc.
Presider and Closing Remarks: Laurie Garrett, Senior Fellow for Global Health, Council on Foreign Relations
12:00 to 12:45 PM Lunch
12:45 to 2:00 PM Meeting
Backgrounder: Food and Drugs by Laurie Garrett and Yanzhong Huang
This meeting is part of the CEO speaker series. This series provides a forum for leading global CEOs to share their priorities and insights before a high-level audience of CFR members. The series aims to educate the CFR membership on the private sector's important role in the policy debate by engaging the global business community's top leadership. Members benefit from hearing CEOs' perspectives as well as interacting with them in an informal setting; in turn, CEOs have the opportunity to highlight the work of their organization and strengthen their relationship with CFR.
A new genetic technology has the potential to cure diseases and boost plant, insect, and human lives, but it also poses profound ethical questions, writes CFR's Laurie Garrett.
Four experts examine the biggest challenge to ensuring the safety of pharmaceuticals traded globally.
Efforts to vaccinate Pakistani children are in peril after the CIA's vaccine ploy to help capture Osama bin Laden, placing the entire region at risk of outbreaks, says CFR's Laurie Garrett.
U.S. trade deals may not be spurring the large price increases and shifts away from lower-cost generics that many predicted.
This interactive map visually plots global outbreaks of measles, mumps, whooping cough, polio, rubella, and other diseases that are easily preventable by inexpensive and effective vaccines. The Global Health Program at the Council on Foreign Relations has been tracking news reports on these outbreaks since the fall of 2008. This project aims to promote awareness of a global health problem that is easily preventable.
David Fedson, an international expert in flu vaccine policy, says the current distribution system could leave many developing countries without access to vaccines during a flu pandemic. Fedson suggests more attention be given to alternative drug therapies.
The collection of essays focusing on different concerns about vaccine prioritization.
An article in the British Medical Journal looks at whether influenza vaccination policy is consistent with the available evidence.
There's a new outsourcing boom in South Asia - and a billion people are jockeying for the jobs. How India became the global hot spot for drug trials.
This CRS report highlights the fact that while encouraging the development of new counterterrorism technologies and ensuring affordable access to new drugs and medical devices are both significant goals, these aspirations may potentially conflict.
This WHO report analyzes the effectiveness of attempts to increase global access to antiretroviral HIV treatments.
The report recommends actions needed to ensure that poor people in developing countries have access to existing and new products to diagnose, treat and prevent the diseases which affect them most.
For the past three years, the Global Health program at the Council on Foreign Relations has been tracking news reports to produce an interactive map plotting global outbreaks of diseases that are easily prevented by inexpensive and effective vaccines.
Laurie Garrett writes that the president-elect’s dangerous views on the safety of vaccines threatens the lives of millions of Americans.
Laurie Garrett writes that the U.N. General Assembly is taking on the danger of antimicrobial resistance that threatens the health of our entire species.
In the absence of credible, strong political leadership, paranoia about disease can go viral. Laurie Garrett and Maxine Builder explain how false fears and suspicions are the enemies when it comes to disease prevention in this op-ed for the Los Angeles Times.
Knopf argues that the only remaining path for South Sudan is for an international transitional administration to run the country for a finite period.
The U.S. relationship with Israel is in trouble. Blackwill and Gordon offer six core policy proposals to repair, redefine, and invigorate the partnership.
To ensure the success of Myanmar's historic democratic transition, the United States should revise its outdated and counterproductive sanctions policy.
CFR President Haass argues for an updated global operating system to address challenges from terrorism to climate change. More
Alden provides an enlightening history of the last four decades of U.S. trade policies and a blueprint for how to keep the United States competitive in a globalized economy. More
In this award-winning biography of Alan Greenspan, Mallaby explores Greenspan's life and legacy and tells the story of the making of modern finance. More
Learn more about CFR’s mission and its work over the past year in the 2016 Annual Report. The Annual Report spotlights new initiatives, high-profile events, and authoritative scholarship from CFR experts, and includes a message from CFR President Richard N. Haass.
Read and download »